Abstract
Structural modifications of the arotinoid molecule RO 13-7410 led to a difference in the teratogenic potencies of more than five orders of magnitude in mice in vivo and in micromass cultures of rat embryonic limb bud cells (Kistler et al. 1990). Five of these retinoids were selected and tested in rat whole embryo culture to determine the suitability of this in vitro test system for the identification of potentially non-teratogenic derivatives among this class of chemicals. The highest concentrations of the compounds with no effects (NOAEL) on general conceptus growth, on differentiation and on the frequency of dysmorphogenic embryos in vitro were compared with the lowest effective teratogenic doses in vivo (LOAEL) or with the concentrations leading to 50% inhibition of limb bud cell differentiation (IC50) in vitro. NOAEL's for the parameters of conceptus development ranged from 10−5 μg/ml (0.03 nM) to 10 μg/ml (28.7 μM) for the compounds tested. These correlated very well with LOAEL and IC50 (R >0.95). The types of dysmorphogenesis in vitro were those typical for retinoids, and for the most part resembled the malformations found in vivo. We conclude that the whole embryo culture system is a useful tool for the preliminary testing of retinoids.
Similar content being viewed by others
References
Bechter R, Hall L (1987) In vitro embryotoxicity and teratogenic potential of etretinate and etretin. Toxicol in Vitro 1: 225–231
Bechter R, Taccard G (1987) Medium and tissue levels of acyclovir and etretinate in the rat whole embryo culture system. In: Nau H, Scott WJ (eds) Pharmacokinetics in teratogenesis, vol 2. CRC Press, Boca Raton, FL, pp 197–208
Brown NA, Fabro S (1981) Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology 24: 65–78
Cicurel L, Schmid BP (1988) Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds. Experientia 44: 833–840
Crettaz M, Baron A, Siegenthaler G, Hunziker W (1990) Ligand specificities of recombinant retinoic acid receptors RARα and RARβ. Biochem J 272: 391–397
Geelen JAG (1979) Hypervitaminosis a induced teratogenesis. Crit Rev Toxicol 6: 351–375
Goulding EH, Pratt RM (1986) Isotretinoin teratogenicity in mouse whole embryo culture. J Craniofac Gen Dev Oncol 6: 99–112
Kistler A (1981) Teratogenesis of retinoic acid in rats. Susceptible stages and suppression of retinoid acid-induced limb malformations by cycloheximide. Teratology 23: 25–31
Kistler A (1987) Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids. Arch Toxicol 60: 403–414
Kistler A, Tsuchiya T, Tsuchiya M, Klaus M (1990) Teratogenicity of arotinoids (retinoids) in vivo and in vitro. Arch Toxicol 64: 616–622
Klug S, Lewandowski C, Wildi L, Neubert D (1989) All-trans retinoic acid and 13-cis-retinoic acid in the rat whole embryo culture: abnormal development due to the all-trans isomer. Arch Toxicol 63: 440–444
Kochhar DM (1967) Teratogenic activity of retinoic acid. Acta Pathol Microbiol Scand 70: 398–404
Lammer EJ, Chem DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW, Lott IT, Richard JM, Sun SC (1985) Retinoic acid embryopathy. N Engl J Med 313: 837–841
New DAT (1978) Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 53: 81–122
Rosa FW, Wilk AL, Kelsey FO (1986) Teratogen update: vitamin A congeners. Teratology 33: 355–364
Seegmiller RE, Harris C, Luchtel DL, Juchau MR (1991) Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro. Teratology 43: 133–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bechter, R., Terlouw, G.D.C., Tsuchiya, M. et al. Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture. Arch Toxicol 66, 193–197 (1992). https://doi.org/10.1007/BF01974014
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01974014